Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Richard Andrew Newcomb, M.D.

Concepts (141)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Richard Newcomb's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Richard Newcomb has written about over time.
Fatigue, 3 publications between 2017 and 2024, average publication date August 2020. Lymphoma, B-Cell, 1 publications between 2021 and 2021, average publication date February 2021. Neoplasms, 7 publications between 2020 and 2024, average publication date August 2021. Leukemia, Myeloid, Acute, 4 publications between 2021 and 2023, average publication date June 2022. Lymphoma, Non-Hodgkin, 3 publications between 2021 and 2024, average publication date August 2022. Immunotherapy, Adoptive, 3 publications between 2021 and 2024, average publication date February 2023. Quality of Life, 16 publications between 2017 and 2024, average publication date April 2023. Adaptation, Psychological, 6 publications between 2022 and 2024, average publication date July 2023. Hematologic Neoplasms, 9 publications between 2023 and 2024, average publication date November 2023. Survivors, 4 publications between 2023 and 2024, average publication date January 2024. Hematopoietic Stem Cell Transplantation, 17 publications between 2022 and 2025, average publication date January 2024. Graft vs Host Disease, 5 publications between 2024 and 2025, average publication date July 2024. Sexual Dysfunction, Physiological, 1 publications between 2024 and 2024, average publication date August 2024.

To see the data from this visualization as text, click here.
Newcomb's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (141)
Explore
_
Co-Authors (64)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.